登革热与输血安全

doi:10.3969/j.issn.1671-2587.2025.03.023

临床输血与检验 ›› 2025, Vol. 27 ›› Issue (3): 427-432.DOI: 10.3969/j.issn.1671-2587.2025.03.023

• 综述 • 上一篇

登革热与输血安全

王义来, 何子毅

东莞市中心血站, 广东东莞 523000

收稿日期:2024-11-29 发布日期:2025-06-23
通讯作者: 何子毅,主要负责血液安全检测和血型血清学研究,（E-mail）zyhe_8@163.com。
作者简介:王义来,主要从事输血医学研究,（E-mail）1448086427@qq.com。

Dengue Fever and Blood Transfusion Safety

WANG Yilai, HE Ziyi

Dongguan Blood Center, Dongguan 523000

Received:2024-11-29 Published:2025-06-23

摘要/Abstract

摘要： 由蚊媒病毒引起的登革热在全球迅速传播,主要发生在热带和亚热带国家。近几年,登革热在我国有扩大流行趋势,目前也有研究表明登革热可通过输血传播,不仅严重威胁我国公共卫生,也对输血安全构成了潜在风险。本文就登革热生物学特征、流行病学、传播途径、临床症状、检测方法、输血安全现状和输血防控策略等方面进行综述。

关键词: 登革热, 登革病毒, 输血安全, 蚊媒传播

Abstract: Dengue fever caused by mosquito-borne viruses is spreading rapidly around the world, mainly in tropical, subtropical countries. In recent years, dengue fever has expanded epidemic trend in our country, now there are also studies showing that dengue fever can be transmitted through blood transfusion, which not only poses a serious threat to public health, but also poses a potential risk to the safety of blood transfusion. This article reviews the biological characteristics, epidemiology, transmission routes, clinical symptoms, detection methods, blood transfusion safety status, blood transfusion prevention, control strategies of dengue fever.

Key words: Dengue fever, Dengue virus, Blood transfusion safety, Mosquito-borne transmission

中图分类号:

R512.8R457.1

王义来, 何子毅. 登革热与输血安全[J]. 临床输血与检验, 2025, 27(3): 427-432.

WANG Yilai, HE Ziyi. Dengue Fever and Blood Transfusion Safety[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2025, 27(3): 427-432.

参考文献

[1] BIFANI A M,SIRIPHANITCHAKORN T,CHOY M M.Intra-host diversity of dengue virus in mosquito vectors[J]. Front Cell Infect Microbiol,2022,12:888804.
[2] POSTLER T S,BEER M,BLITVICH B J,et al.Renaming of the genus Flavivirus to Orthoflavivirus and extension of binomial species names within the family Flaviviridae[J]. Arch Virol,2023,168(9):224.
[3] ZHAO Z,YUE Y J,LIU X B,et al.The patterns and driving forces of dengue invasions in China[J]. Infect Dis Poverty,2023,12(1):42.
[4] KOK B H,LIM H T,LIM C P,et al.Dengue virus infection-a review of pathogenesis,vaccines,diagnosis and therapy[J]. Virus Res,2023,324:199018.
[5] CHEN S,WU Z,WANG M S,et al.Innate immune evasion mediated by Flaviviridae non-structural proteins[J]. Viruses,2017,9(10):291.
[6] MA M M,WU S A,HE Z J,et al.New genotype invasion of dengue virus serotype 1 drove massive outbreak in Guangzhou,China[J]. Parasit Vectors,2021,14(1):126.
[7] 张复春,何剑峰,彭劼,等. 中国登革热临床诊断和治疗指南[J]. 中华内科杂志,2018,57(9): 642-648.
[8] WHO. Dengue and severe dengue[EB/OL]. (2024-04-23)https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue.
[9] KHAN S,AKBAR S M F,YAHIRO T,et al. Dengue infections during COVID-19 period:reflection of reality or elusive data due to effect of pandemic[J]. Int J Environ Res Public Health,2022,19(17):10768.
[10] KHAN M B,YANG Z S,LIN C Y,et al.Dengue overview:an updated systemic review[J]. J Infect Public Health,2023,16(10):1625-1642.
[11] XU C D,XU J Y,WANG L.Long-term effects of climate factors on dengue fever over a 40-year period[J]. BMC Public Health,2024,24(1):1451.
[12] KHAN M,PEDERSEN M,ZHU M,et al.Dengue transmission under future climate and human population changes in mainland China[J]. Appl Math Model, 2023,114:785-798.
[13] 熊益权,陈清.1978~2014年我国登革热的流行病学分析[J].南方医科大学学报,2014,34(12):1822-1825.
[14] WU T T,WU Z D,LI Y P.Dengue fever and dengue virus in the people's republic of China[J]. Rev Med Virol, 2022,32(1):e2245.
[15] 岳玉娟,刘小波,郭玉红,等. 2020—2022年中国登革热时空分布及相关环境因素分析[J]. 环境卫生学杂志, 2023,13(5):341-345.
[16] 岳玉娟,刘小波,任东升,等. 中国大陆2005—2020年登革热流行病学特征分析[J]. 中国媒介生物学及控制杂志, 2023,34(6):761-766.
[17] YUE Y J,LIU Q Y,LIU X B,et al.Dengue fever in mainland China,2005—2020:a descriptive analysis of dengue cases and Aedes data[J]. Int J Environ Res Public Health,2022,19(7):3910.
[18] 高娜,盛子洋. 登革热疾病负担及预防控制策略中国专家共识[J]. 中国人兽共患病学报,2024,40(6):489-497.
[19] BREM J,ELANKESWARAN B,ERNE D,et al.Dengue “homegrown” in Europe (2022 to 2023)[J]. New Microbes New Infect,2023,56:101205.
[20] 林健燕,郭泽强,邱昌文. 非蚊媒途径传播登革病毒的研究进展[J]. 中国热带医学,2018,18(4):406-409.
[21] ZAMBRANO L E A,ZEVALLOS V M V,SORAYA G V, et al. Transplacental transmission of dengue infection[J]. World J Virol,2024,13(3):91325.
[22] 林健燕,郭泽强,邱昌文,等. 登革热的流行形势及其对血液安全性的影响[J]. 广西医学,2017,39(4):517-518.
[23] CÁCERES MUNAR B A,URBINA A,ORTÍZ T,et al. High prevalence of dengue,Zika,and chikungunya viruses in blood donors during a dengue outbreak and an endemic period in Colombia[J]. Front Med (Lausanne), 2024,11:1380129.
[24] CUI F F,HE F W,HUANG X R,et al.Dengue and dengue virus in Guangdong,China,1978-2017:epidemiology,seroprevalence,evolution,and policies[J]. Front Med (Lausanne),2022,9:797674.
[25] 林芬,杨辉,杨立业,等. 528例登革热患者临床表现与实验室数据的回顾性分析[J]. 检验医学与临床, 2017,14(12): 1726-1728.
[26] Thomas S J, Rothman A L, Srikiatkhachorn A, et al.Dengue virus infection: clinical manifestations and diagnosis[J]. Waltham, MA, USA: UpToDate, 2018.
[27] 中华医学会感染病学分会,中华医学会热带病与寄生虫学分会,中华中医药学会急诊分会.中国登革热临床诊断和治疗指南[J]. 传染病信息,2018,31(5):385-392.
[28] 刘铁柱,李建东. 登革热病原学与实验室检测技术研究进展[J]. 病毒学报,2024,40(3):588-597.
[29] 严延生,翁育伟. 寨卡病毒与登革热病毒交叉反应抗体引发严重性疾病的关系[J]. 中国人兽共患病学报,2017, 33(2):93-97.
[30] BHATT P,SABEENA S P,VARMA M,et al.Current understanding of the pathogenesis of dengue virus infection[J]. Curr Microbiol,2021,78(1):17-32.
[31] 秦圆方,张欣,张复春,等. 登革热抗原抗体联合检测与双抗体检测效能比较[J]. 江苏预防医学,2023,34(6):770-772.
[32] IQBAL G,JAVED H,RAZA F A,et al.Diagnosis of acute dengue virus infection using enzyme-linked immunosorbent assay and real-time PCR[J]. Can J Infect Dis Med Microbiol,2023,2023:3995366.
[33] POLLAK N M,OLSSON M,AHMED M,et al.Rapid diagnostic tests for the detection of the four dengue virus serotypes in clinically relevant matrices[J]. Microbiol Spectr,2023,11(1):e0279622.
[34] POZZETTO B,MEMMI M,GARRAUD O.Is transfusion-transmitted dengue fever a potential public health threat?[J]. World J Virol,2015,4(2):113-123.
[35] CHUANG V W, WONG T Y, LEUNG Y H, et al.Review of dengue fever cases in Hong Kong during 1998 to 2005[J]. Hong Kong Medical Journal,2008,14(3):170.
[36] TAMBYAH P A,KOAY E S C,POON M L M,et al. Dengue hemorrhagic fever transmitted by blood transfusion[J]. N Engl J Med,2008,359(14):1526-1527.
[37] LEVI J E,NISHIYA A,FÉLIX A C,et al. Real-time symptomatic case of transfusion-transmitted dengue[J]. Transfusion,2015,55(5):961-964.
[38] ALMEIDA F J,PACHECO J T,FARIAS C G A,et al. Dengue:a hidden threat in blood transfusions amidst Brazil's largest outbreak?[J]. Lancet Infect Dis,2025, 25(1):e10.
[39] KARIM F,NASIR N,MOIZ B.Transfusion transmitted dengue:One donor infects two patients[J]. Transfus Apher Sci,2017,56(2):151-153.
[40] STRAMER S L,LINNEN J M,CARRICK J M,et al.Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico[J]. Transfusion, 2012,52(8):1657-1666.
[41] PERERA L,DE ZOYSA N,JAYARAJAH U,et al.Transfusion-transmissible dengue infections[J]. Trans R Soc Trop Med Hyg,2020,114(11):866-882.
[42] GIMÉNEZ-RICHARTE Á,ORTIZ DE SALAZAR M I,GIMÉNEZ-RICHARTE M P,et al. Transfusion-transmitted arboviruses:Update and systematic review[J].PLoS Negl Trop Dis,2022,16(10):e0010843.
[43] KAUR P,KAUR G.Transfusion support in patients with dengue fever[J]. Int J Appl Basic Med Res,2014, 4(Suppl 1):S8-S12.
[44] GOH Z J,LI R Q,WANG M X,et al. Transfusion of blood products and clinical outcomes for patients with dengue fever:a systematic review and meta-analysis[J]. Open Forum Infect Dis,2024,11(9):ofae507.
[45] YAN G,TAMBYAH P.Transfusion-transmitted infections:lessons from dengue in Taiwan[J]. J Infect Dis,2022,225(9):1497-1499.
[46] CHEN Y Y,LU C T,TSAI M H,et al.Dengue virus ribonucleic acid detection rates in blood donors correlate with local infection incidences during a dengue outbreak in Taiwan[J]. J Infect Dis,2022,225(9):1504-1512.
[47] LI L,LI Y,LU S F,et al.Epidemiological survey and screening strategy for dengue virus in blood donors from Yunnan Province[J]. BMC Infect Dis,2021,21(1):104.
[48] 林健燕,广西献血员登革热流行情况及其对血液安全的影响[R].广西壮族自治区,南宁输血医学研究所,2019-03-26.
[49] 李军伟,李小伟,陈丹. 血清型登革热病毒PCR方法学评估与应用[J]. 河南预防医学杂志,2017,28(10):726-729.
[50] KATZELNICK L C,COELLO ESCOTO A,HUANG A T,et al.Antigenic evolution of dengue viruses over 20 years[J]. Science,2021,374(6570):999-1004.
[51] ST JOHN A L,RATHORE A P S. Adaptive immune responses to primary and secondary dengue virus infections[J]. Nat Rev Immunol,2019,19(4):218-230.
[52] 郭泽强,林健燕,罗必泰,等. 南宁市登革热大流行后人群中抗原抗体的变化[J]. 中国热带医学,2019,19(4):348-351.
[53] BUSCH M P,SABINO E C,BRAMBILLA D,et al.Duration of dengue viremia in blood donors and relationships between donor viremia,infection incidence and clinical case reports during a large epidemic[J]. J Infect Dis,2016,214(1):49-54.
[54] PETERSEN L R,TOMASHEK K M,BIGGERSTAFF B J.Estimated prevalence of dengue viremia in Puerto Rican blood donations,1995 through 2010[J]. Transfusion, 2012,52(8):1647-1651.
[55] KULKARNI R,TIRAKI D,WANI D,et al.Risk of transfusion-associated dengue:screening of blood donors from Pune,western India[J]. Transfusion,2019, 59(2):458-462.
[56] GIMÉNEZ-RICHARTE Á,ORTIZ DE SALAZAR M I,GIMÉNEZ-RICHARTE M P,et al. Pathogen inactivation methods to prevent transfusion-transmissible arboviruses: a systematic review and meta-analysis[J]. Trop Med Int Health,2023,28(4):262-274.
[57] 康澜,李世林,杨春晖.血液成分中病原体灭活技术及其研究进展[J]. 临床输血与检验,2022,24(4):521-527.
[58] 李玉佳,段晓琼,王艳翠,等. 四种病毒灭活方法用于登革病毒灭活效果的比较[J]. 中国输血杂志,2020,33(2):109-113.
[59] STRAMER S L,LANTERI M C,BRODSKY J P,et al.Mitigating the risk of transfusion-transmitted infections with vector-borne agents solely by means of pathogen reduction[J]. Transfusion,2022,62(7):1388-1398.
[60] 王义来,陈庆恺,韩国伟,等. 寨卡病毒与血液安全[J]. 临床输血与检验,2024,26(6):859-864.

登革热与输血安全

Dengue Fever and Blood Transfusion Safety

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	赵桐茂. RhCE抗原错配是中国输血患者的主要风险[J]. 临床输血与检验, 2025, 27(3): 289-290.
[2]	易萌, 樊斌, 段晓琼, 陈利民. 隐匿性乙肝感染对输血安全的影响及应对策略^*[J]. 临床输血与检验, 2025, 27(2): 254-260.
[3]	王义来, 陈庆恺, 韩国伟, 何子毅. 寨卡病毒与血液安全[J]. 临床输血与检验, 2024, 26(6): 859-864.
[4]	朱海洋, 贺理, 王勇军. 改进后大量输血策略在原位肝移植手术中的应用研究[J]. 临床输血与检验, 2023, 25(6): 733-737.
[5]	李正峰, 王佳, 陈萍, 甘珊, 李好, 段灵, 陈鑫, 杨柳春, 王阳, 胡红兵. 儿科住院拟输血患者意外抗体阳性结果分布及影响因素横断面研究[J]. 临床输血与检验, 2023, 25(3): 374-378.
[6]	陈蕊, 吕孟兴, 尹加忠, 沈经纬, 熊荣, 白云艳, 周文彪, 王旭, 杨琦, 屈柯暄. 云南省地中海贫血儿童输血安全策略的研究^*[J]. 临床输血与检验, 2022, 24(6): 710-715.
[7]	谢惠益, 周载鑫, 杨玥, 王星怡, 李津杞, 牟显尧, 顾海慧, 钱宝华. 抗-M抗体影响血型鉴定及对临床输血的影响^*[J]. 临床输血与检验, 2022, 24(6): 716-720.
[8]	王文婷, 刘启旺, 张嵘, 党盼玉, 顾顺利, 胡兴斌, 刘杨, 尹文. 亲体子宫移植患者围术期临床用血情况的分析与探讨[J]. 临床输血与检验, 2021, 23(5): 551-555.
[9]	邸艳辉, 管行, 寇立舵, 白薇, 王新华. AIHA患者血型血清学特征及输注悬浮红细胞疗效分析[J]. 临床输血与检验, 2021, 23(4): 455-458.
[10]	杨春晨, 戎瑞明, 李杨, 蒋密, 周蓉. 基于Cov-AHP-模糊综合评价法构建输血病历质量评价模型[J]. 临床输血与检验, 2021, 23(2): 192-196.
[11]	张保萍, 张嵘, 王文婷, 安群星, 尹文, 胡兴斌. 谱细胞鉴定剂量效应分析偏差致抗-C抗体漏检1例[J]. 临床输血与检验, 2021, 23(2): 236-239.
[12]	王娟, 王文婷, 胡兴斌, 尹文. 血浆置换成功治疗难治性莫旺综合征合并膜性肾病1例[J]. 临床输血与检验, 2021, 23(1): 109-111.
[13]	桂嵘, 王勇军, 黄雪原, 马金旗, 赵国胜, 王露楠, 王学锋, 杨瑞锋. 关于目前术前/输血前患者感染性疾病筛查的思考与探索^*[J]. 临床输血与检验, 2020, 22(6): 565-567.
[14]	徐倩, 姜黎明, 欧阳春. 乙脑病毒E蛋白抗体在THP-1细胞中对增强DENV-Ⅱ感染的作用研究^*[J]. 临床输血与检验, 2020, 22(6): 594-598.
[15]	王丽, 刘颖, 李文娟, 王健欣, 徐晓欣. 8 775例拟输血患者不规则抗体检出情况及危险因素分析[J]. 临床输血与检验, 2020, 22(5): 480-483.